i3 Verticals vs Exzeo
IIIV and XZO side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IIIV and XZO compare
Exzeo is the larger company, worth 2.8 times as much as i3 Verticals ($1.4B against $505M).
On earnings, Exzeo is cheaper: it trades at 16.1× trailing earnings, against 49.2× for i3 Verticals.
Exzeo grew revenue faster over the last twelve months (21.8% versus 4.1% for i3 Verticals).
Exzeo keeps more of each dollar of sales as profit, with a net margin of 39.1% compared with 3.9% at i3 Verticals.
Exzeo scores higher on the StockData Score (14 against 9 for i3 Verticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IIIV | XZO |
|---|---|---|
| Size and price | ||
| Market cap | $505M | $1.4B |
| Share price | $19.18 | $15.89 |
| Change, 1 year | −32.8% | −10.7% |
| Change, 5 years | −1.3% | – |
| Beta (5Y) | −0.67 | 1.57 |
| Employees | 1,202 | – |
| StockData Score | ||
| Total score | 9 | 14 (better) |
| Valuation score | 3 | 3 |
| Growth score | 1 | 2 (better) |
| Performance score | 2 | 3 (better) |
| Health score | 3 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 49.2× | 16.1× (better) |
| P/S | 2.3× (better) | 6.5× |
| P/B | 1.8× (better) | 5.0× |
| EV/EBITDA | 21.1× | 11.8× (better) |
| P/FCF | 10.1× (better) | 17.6× |
| FCF yield | 9.9% (better) | 5.7% |
| Fair value | $20.67 | $25.47 |
| Margin of safety | 7.2% | 37.6% (better) |
| Growth | ||
| Revenue growth (TTM) | 4.1% | 21.8% (better) |
| Revenue growth, 5Y average | 7.3% | – |
| Net income growth (TTM) | −93.6% | 53.5% (better) |
| EPS growth (TTM) | −92.9% | 43.5% (better) |
| Profitability | ||
| Gross margin | – | 62.3% |
| Operating margin | 2.7% | 48.5% (better) |
| Net margin | 3.9% | 39.1% (better) |
| FCF margin | 22.9% | 36.8% (better) |
| Return on equity | 2.6% | 57.2% (better) |
| Return on invested capital | 1.2% | 143% (better) |
| Financial health | ||
| Debt / equity | 0.41 (better) | 0.00 |
| Net debt / EBITDA | 3.20 | – |
| Current ratio | 1.21 | 1.85 (better) |
| Altman Z-score | 2.01 | 10.79 (better) |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Buyback yield | 27.1% | – |
| Shareholder yield | 27.1% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 84.8% | 7.1% |
| Held by insiders | 35.3% | 9.2% |
| Insider net buying, 12 months | $610K | $2.3M (better) |
| Short interest, % of float | 16.7% | 2.0% |
Go deeper
- IIIV stock overview
- IIIV income statement
- IIIV valuation and score
- XZO stock overview
- XZO income statement
- XZO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.